Targeted therapy for advanced esophagogastric adenocarcinoma.

S Kordes; A Cats; S L Meijer; H W M van Laarhoven

首页> 外文期刊>Critical reviews in oncology/hematology >Targeted therapy for advanced esophagogastric adenocarcinoma.

【24h】

Targeted therapy for advanced esophagogastric adenocarcinoma.

机译：晚期食管胃腺癌的靶向治疗。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Targeted therapy in EGC is emerging. Improved insight in the biologic background of EGC is needed to improve patient selection, combine agents and discover new targets and agents. This may improve outcome for metastasized EGC patients.

机译：EGC中的靶向治疗正在兴起。需要改善对EGC生物学背景的洞察力，以改善患者选择，结合药物并发现新的靶标和药物。这可以改善转移的EGC患者的预后。

著录项

来源
《Critical reviews in oncology/hematology》 |2014年第1期|共9页
作者
S Kordes; A Cats; S L Meijer; H W M van Laarhoven;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Targeted therapy for advanced esophagogastric adenocarcinoma. [J] . S Kordes, A Cats, S L Meijer, Critical reviews in oncology/hematology . 2014,第1期

机译：晚期食管胃腺癌的靶向治疗。
2. Phase II trial of preoperative irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for resectable locally advanced gastric and esophagogastric junction adenocarcinoma. [J] . Rivera F, Galan M, Tabernero International Journal of Radiation Oncology, Biology, Physics . 2009,第5期

机译：术前伊立替康-顺铂继之并用伊立替康-顺铂和放疗用于可切除的局部晚期胃和食管胃交界处腺癌的II期试验。
3. Epidermal growth factor receptor targeted therapy with gefitinib in locally advanced and metastatic primary lung adenocarcinoma. [J] . Liam CK, Pang YK, Leow CH Respirology : . 2006,第3期

机译：吉非替尼治疗局部晚期和转移性原发性肺腺癌的表皮生长因子受体靶向治疗。
4. Multiple Functions of Cancer Targeting, Imaging and Photothermal Therapy by Au-based Theranostics Released from Advanced Tissue Engineering Scaffolds [C] . Lin Guo, Min Wang Society for Biomaterials annual meeting and exposition . 2018

机译：从先进的组织工程支架中释放的基于金的治疗学的癌症靶向，成像和光热疗法的多功能。
5. Mechanism of action of, and combination chemotherapy with isoprenoids perillyl alcohol, farnesol, and geraniol in in vitro and in vivo models of human pancreatic adenocarcinoma. [D] . Wiseman, Dean Allen. 2004

机译：异戊二烯类紫苏醇，法尼醇和香叶醇在人胰腺癌的体内和体外模型中的作用机理以及联合化疗的作用。
6. Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis [O] . Jing Li, Qun Zhao, Xueke Ge, 2021

机译：与新辅助化疗相比Neoadjuvant ChemorAdootherapy改善了食管胃癌的局部晚期腺癌的存活：倾向得分匹配分析
7. Target Defining of Postoperative Radiotherapy for Locally Advanced Siewert’s II/III Adenocarcinoma of Esophagogastric Junction: Based on Patterns of Recurrence after Radical Resection [O] . J. Wang, L.Y. Guo, Q. Liu, 2020

机译：针对局部高级Siewert II / III腺癌食管古代交界处的术后放射治疗的目标定义：基于激进切除后复发模式
8. Modulation of T Cell Tolerance in a Murine Model for Immunotherapy of Prostatic Adenocarcinoma. Addendum [R] . Hurwitz, A. A. 2007

机译：小鼠模型中T细胞耐受的调节对前列腺癌的免疫治疗。附录

Targeted therapy for advanced esophagogastric adenocarcinoma.

摘要

著录项

相似文献

相关主题

期刊订阅